What is Dorzolamide ophthalmic?
Category: Prescription Drugs
Most popular types: Trusopt
Dorzolamide ophthalmic is an antiglaucoma ophthalmic agent and a carbonic anhydrase inhibitor. It is used for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Glaucoma | 7 | 1 | |
| Blurry vision | 1 | 0 | |
| Toxic levels of non-steroidal anti-inflammatory drug (NSAID) | 1 | 0 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Why patients stopped taking Dorzolamide ophthalmic
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Other | 1 | |
| Side effects too severe | 1 |
Duration
Stopped taking Dorzolamide ophthalmic
| Duration | Patients | Percentage |
|---|---|---|
| 1 - 6 months | 2 |
| Cost per month | Evaluations | Percentage |
|---|---|---|
| $200+ | 0 | |
| $100-199 | 0 | |
| $50-99 | 0 | |
| $25-49 | 0 | |
| < $25 | 1 | |
| Not specified | 0 |
What people switch to and from
Patients started taking Dorzolamide ophthalmic after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Brimonidine ophthalmic (Alphagan Eye Drops) | 1 | |
| Brinzolamide/Brimonidine Tartrate (Simbrinza) | 1 |
Patients stopped taking Dorzolamide ophthalmic and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Brinzolamide/Brimonidine Tartrate (Simbrinza) | 1 |
Last updated: